The Department of Epidemiology & Public Health & HRB Clinical Research Facility Cork

Presents

Professor Neil R Poulter CV Outcome Trials in Type 2 Diabetes: A Review

Organisers: Brenda Lynch & Prof. Patricia Kearney

Professor of Preventive Cardiovascular Medicine, Imperial College London,
Co-Director of the International Centre for Circulatory Health and Imperial Clinical Trials Unit.

Professor Neil Poulter qualified at St Mary’s Hospital, London in 1974. From 1980 to 1985, he co-ordinated a hypertension research programme at the Wellcome Trust Research Laboratories, Kenya. In 1986 he gained an MSc in Epidemiology with distinction at the London School of Hygiene and Tropical Medicine. Thereafter, he was Co-PI of the WHO Oral Contraceptive case-control Study at University College London.

In 1997 Professor Poulter was appointed Professor of Preventive Cardiovascular Medicine at Imperial College London, where he is currently Co-Director of the International Centre for Circulatory Health and of the Imperial Clinical Trials Unit. He is an Honorary Consultant Physician and Epidemiologist at the Peart-Rose (Hypertension and CVD Prevention) Clinic based at the Hammersmith Hospital, London, where he is actively involved in the treatment of patients with hypertension and related problems. He was President of the British Hypertension Society from 2003-2005 and is currently a Member of the Executive Committee and President Elect of the International Society of Hypertension; Member of the World Heart Federation, Scientific Policy and Advocacy Committee (SPAC); and Chair of the Council, International Society of Cardiovascular Disease, Epidemiology and Prevention (ISCEP). In 2008 he was elected as one of the Inaugural Senior Investigators of the NIHR in UK and in 2009 he was elected as a fellow of the Academy of Medical Sciences.

Professor Poulter has contributed chapters to several major textbooks and published over 385 papers in peer-reviewed medical journals. Professor Poulter is among the top 1% most cited academics in clinical medicine as reported in the Thomson Reuters Highly Cited Researcher 2014 report. He has played a senior role in several international trials including ASCOT and ADVANCE. Other research activities include the investigation and management of hypertension, dyslipidaemia and type 2 diabetes, the ‘Barker Hypothesis’, the CV effects of oestrogen and progesterone, prevention of type 2 diabetes, abdominal aortic aneurysm and ethnic differences in CVD.

свернуть